Nuclear Medicine Basics: What Radiologists & Clinicians Should Know

Added:

Nuclear Medicine Basics
Debunking Radiology Myths
I-131 Therapy and Safety
Radiopharmaceuticals and Imaging
Common Isotopes and Physics
Therapeutic Radiopharmaceuticals
Thyroid Cancer Imaging
Sentinel Lymph Node Mapping
VQ Scans and Bone Scans
Advanced Nuclear Imaging

Nuclear Medicine Basics

0:00
Playing Section
  • 1

    Defines nuclear medicine as a specialty combining internal radiation with imaging.

  • 2

    Explains the historical and current relationship between nuclear medicine and radiology.

Basic atomic physics and radioactivity, including isotopes, half-lives, and radioactive decay modes (alpha, beta, and gamma emissions).
The conceptual difference between anatomical imaging (such as CT and MRI) and functional or molecular imaging.
Fundamentals of human physiology and cellular metabolism, as radiopharmaceuticals are designed to target specific biological pathways.
General radiation safety principles, including the biological effects of ionizing radiation and the ALARA (As Low As Reasonably Achievable) concept.
Hybrid imaging modalities, specifically the integration and clinical utility of PET/CT, PET/MRI, and SPECT/CT systems.
The clinical paradigm of Theranostics, utilizing specific molecular targets for both diagnostic imaging and targeted radionuclide therapy (e.g., Lu-177 PSMA).
Clinical image interpretation protocols, focusing on distinguishing normal physiological tracer biodistribution from pathological uptake and identifying common artifacts.
Radiopharmacy operations, covering the synthesis, sterile preparation, and quality control of PET and SPECT radiotracers.
10K views201likes1:51:08@universityofutahdepartment8630Original Release: 2020-04-22

Nuclear medicine is a medical specialty that uses internalized radiation (via IV injection, ingestion, or other routes) combined with specialized imaging technology to diagnose and treat diseases, particularly cancers and metabolic disorders, by exploiting the unique physiological targeting properties of radiopharmaceuticals that accumulate in specific tissues or processes.